Beijing Hotgen Biotech Co., Ltd.

Shanghai Stock Exchange 688068.SS

Beijing Hotgen Biotech Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 61.23%

Beijing Hotgen Biotech Co., Ltd. Gross Profit Margin is 61.23% for the year ending December 31, 2023, a 14.00% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Beijing Hotgen Biotech Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 53.71%, a -9.79% change year over year.
Beijing Hotgen Biotech Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 59.54%, a -5.51% change year over year.
Beijing Hotgen Biotech Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 63.01%, a -13.83% change year over year.
Beijing Hotgen Biotech Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 73.12%, a -0.84% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shanghai Stock Exchange: 688068.SS

Beijing Hotgen Biotech Co., Ltd.

CEO	Mr. Changqing Lin
IPO Date	Sept. 30, 2019
Location	China
Headquarters	Zhongguancun High-end Medical Device Ind
Employees	1,036
Sector	Health Care
Industries Biotechnology Chemicals & Advanced Materials Pharmaceuticals

Description

Beijing Hotgen Biotech Co., Ltd. engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine. It offers drug detection, CDC, Up-conversion luminescence technology, colloidal gold, CLIA, sugar capture, microfluidic, and gene detection products for testing of intestinal microorganisms, gastrointestinal foodborne infections, insect-borne diseases, respiratory pathogens, infectious diseases, Ebola virus antigen, biological warfare agents, microorganisms, and mycotoxins. The company was founded in 2005 and is based in Beijing, China.

Key trends

Past 5 years